All peptides
CJC-1295 + Ipamorelin
Also known as: GH secretagogue blend (no-DAC)
Research / Investigational
CJC-1295 (no-DAC) is a modified GHRH analog; combined with the selective GH secretagogue ipamorelin to study synergistic GH pulse amplification.
Buy CJC-1295 + Ipamorelin on American Peptides
Affiliate link — we may earn a commission at no extra cost to you.
Overview
CJC-1295 (no-DAC) is a modified GHRH analog; combined with the selective GH secretagogue ipamorelin to study synergistic GH pulse amplification.
FDA Approval Status
Not approved by the FDA. Investigational or intended for research purposes only.
Mechanism of Action
GHRH-receptor activation (CJC-1295) with ghrelin-receptor agonism (ipamorelin).
Current Research
Individual peptides studied; combination widely used off-label in research settings.
Research strength: Preliminary
Potential Medical Uses
- Investigational only
Potential Benefits
- Amplified endogenous GH pulses (research)
Known Side Effects
- Injection-site reactions
- Water retention
- Head-rush at dosing
Contraindications
- Active malignancy
- Pregnancy
Drug Interactions
- Insulin/insulin secretagogues (theoretical)
Administration Methods
- Subcutaneous injection (research)
Half-life
CJC-1295 no-DAC ~30 min; ipamorelin ~2 h
Reconstitution
Bacteriostatic water; concentration varies.
Storage & Handling
Refrigerated reconstituted; use within ~30 days.
References & Sources
Frequently Asked Questions
Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.